朗欧医药LONGER品牌怎么样 申请店铺

我要投票 朗欧医药LONGER在医疗器械行业中的票数:661 更新时间:2025-12-14
朗欧医药LONGER是哪个国家的品牌?「朗欧医药LONGER」是 深圳朗欧医药集团有限公司 旗下著名品牌。该品牌发源于广东省深圳市,由创始人邹翔在2004-07-09期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力朗欧医药LONGER品牌出海!将品牌入驻外推网,定制朗欧医药LONGER品牌推广信息,可以显著提高朗欧医药LONGER产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

朗欧医药LONGER怎么样

朗欧医药集团成立于2000年6月,是一家集医药研发、生产、销售的集团公司。集团拥有江苏朗欧药业有限公司(江苏徐州)、烟台中洲制药有限公司(山东烟台)、广西玉兰制药有限公司(广西梧州)、江苏圣朗药业有限公司(江苏南京)等GMP工业以及深圳朗欧及武汉朗帛GSP商业,拥有员工1500余人。

朗欧集团拥有丰富的产品线。产品覆盖抗生素类、消化类、神经类、精神类、麻醉类、呼吸类、心血管类等治疗领域,拥有221个药品批文。其中,广西玉兰制药有限公司产品定位:清热解毒专家,拥有痔疮片、功劳去火片、利尔眠片、桑椹颗粒等品种;烟台中洲制药有限公司产品定位:妇儿健康的守护者,拥有金莲花分散片、血宁片、心安宁片、叶酸片等品种。拥有复方双花颗粒、胃肠宁片、胃肠宁颗粒、格列吡嗪胶囊、复方氨酚葡锌片等核心产品;江苏朗欧药业有限公司产品定位:精麻药经典品牌,拥有氯硝西泮注射液、艾司唑仑注射液、氟哌啶醇注射液、氯普噻吨注射液、多塞平注射液等一批精麻药品。

朗欧集团拥有强大的生产能力。公司拥有片剂、胶囊剂、颗粒剂、糖浆剂、茶剂、注射剂等多条生产线。其中,广西玉兰制药有限公司年产片剂22亿片、颗粒剂1500吨、糖浆剂60万升、茶剂1300吨;烟台中洲制药有限公司年产片剂10亿片、胶囊剂2亿粒;江苏圣朗药业有限公司年产片剂10亿片、胶囊5亿粒、颗粒5千万袋、中药提取1000吨;江苏朗欧药业有限公司(原徐州莱恩药业有限公司)年产小容量注射剂可达10亿支。

朗欧集团拥有健全的营销网络。在全国建有10大事业部(国药事业部、心血管事业部、儿药事业部、精麻药事业部、呼吸事业部、抗感染事业部、坤药事业部、药械事业部、基低药事业部、品牌事业部)、30个省总大办事处,近千名销售精英。营销触角深入地县,产品进入全国10000多家医院及第2、第3终端。

朗欧集团拥有深厚的企业文化。多年的发展朗欧孕育和沉淀了具有自身特色的企业文化,倡导“团队精神、以人为本、孝敬父母、社会责任”的核心价值观;打造“感恩文化、欣赏文化、反省文化、宝宝文化、PK文化、勤俭文化及快乐文化”的企业文化;树立“做百年朗欧,做百强朗欧”的企业愿景;坚守“助力民族制药,守护国人健康”的企业使命。

朗欧集团拥有创新的发展理念。从产品创新到学术创新,从渠道创新到模式创新,朗欧集团的发展,一直就在创新的路上......聚焦资源,合力营销,联盟商业,创造多赢,这是朗欧在新医药形势下的再次创新之举。创新的朗欧,开放的朗欧,诚信的朗欧,共享的朗欧,愿与您一道搭建工商联盟的战略合作平台,同舟共济,携手奋进。


Founded in June 2000, longou Pharmaceutical Group is a group company integrating pharmaceutical research and development, production and sales. The group has GMP industries such as Jiangsu longou Pharmaceutical Co., Ltd. (Xuzhou, Jiangsu), Yantai Zhongzhou Pharmaceutical Co., Ltd. (Yantai, Shandong), Guangxi Yulan Pharmaceutical Co., Ltd. (Wuzhou, Guangxi), Jiangsu Shenglang Pharmaceutical Co., Ltd. (Nanjing, Jiangsu), and GSP businesses of Shenzhen longou and Wuhan Longbo, with more than 1500 employees. Longou group has a rich product line. The products cover antibiotic, digestive, neurological, mental, anesthetic, respiratory, cardiovascular and other treatment fields, with 221 drug approvals. Among them, the product positioning of Guangxi Yulan Pharmaceutical Co., Ltd.: a heat clearing and detoxifying expert, with hemorrhoids tablets, Gonglaoquhuo tablets, lilmian tablets, mulberry granules and other varieties; Yantai Zhongzhou Pharmaceutical Co., Ltd. Product Positioning: the guardian of women and children's health, with Jinlianhua dispersible tablets, Xuening tablets, Xinanning tablets, folic acid tablets and other varieties. The company has core products such as compound Shuanghua granules, Weichangning tablets, Weichangning granules, glipizide capsules, compound paracetamol and zinc gluconate tablets, etc.; the product positioning of Jiangsu longou Pharmaceutical Co., Ltd.: classic brand of fine anesthetics, with a batch of fine anesthetics such as clonazepam injection, estazolam injection, haloperidol injection, chloroprothiazide injection, doxepin injection, etc. Longou group has a strong production capacity. The company has tablet, capsule, granule, syrup, tea, injection and other production lines. Among them, Guangxi Yulan Pharmaceutical Co., Ltd. has an annual output of 2.2 billion tablets, 1500 tons of granules, 600000 liters of syrup and 1300 tons of tea; Yantai Zhongzhou Pharmaceutical Co., Ltd. has an annual output of 1 billion tablets and 200 million capsules; Jiangsu Shenglang Pharmaceutical Co., Ltd. has an annual output of 1 billion tablets, 500 million capsules, 50 million bags of granules and 1000 tons of traditional Chinese medicine extraction; Jiangsu longou Pharmaceutical Co., Ltd. (formerly Xuzhou Laien) Pharmaceutical Co., Ltd.) has an annual output of 1 billion small volume injections. Longou group has a sound marketing network. There are 10 business departments (national drug business department, cardiovascular business department, pediatrics business department, fine and anesthetics business department, respiratory business department, anti infection business department, Kun drug business department, pharmaceutical machinery business department, basic and low drug business department, brand business department), 30 provincial general offices and nearly 1000 sales elites. The products have entered more than 10000 hospitals and the second and third terminals. Longou group has a profound corporate culture. With years of development, longou has nurtured and precipitated its own corporate culture with its own characteristics, advocating the core values of "team spirit, people-oriented, filial piety to parents, and social responsibility"; building a corporate culture of "gratitude culture, appreciation culture, reflection culture, baby culture, PK culture, thrifty culture and happy culture"; establishing an enterprise of "being a longou for a century, being a top 100 longou" Vision: adhere to the corporate mission of "help national pharmaceutical, protect people's health". Longou group has innovative development concept. From product innovation to academic innovation, from channel innovation to model innovation, the development of longou group has always been on the way of innovation... Focusing on resources, joint marketing, alliance business, creating multi win, this is the second innovation of longou in the new pharmaceutical situation. The innovative, open, honest and shared longou are willing to work with you to build a strategic cooperation platform for business alliance, work together in the same boat and forge ahead hand in hand.

本文链接: https://brand.waitui.com/40e73e693.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

应对老年护理刚需,四部门发布《老年护理服务能力提升行动方案》

近日,国家卫生健康委、国家医保局、国家中医药局和国家疾控局四部门发布《老年护理服务能力提升行动方案》(以下简称《行动方案》)提出,到2027年,老年护理资源有效扩容,覆盖机构、社区、居家的老年护理服务体系逐步完善,从业人员服务能力不断提升,老年护理服务持续改善,服务连续性、可及性、规范性持续提高,老年人获得感不断增强。提升老年护理服务能力是深入贯彻实施积极应对人口老龄化国家战略的具体举措。截至2024年底,我国60岁及以上人口数达3.1亿,占总人口的22%,老年人特别是失能老年人对医疗护理服务呈现迫切的刚性需求。(央视新闻)

2小时前

消息人士称英伟达考虑提高H200芯片产量

消息人士称,英伟达考虑提高H200芯片产量。(新浪财经)

2小时前

中国造高端工业母机在沈阳下线交付

记者13日从通用技术沈阳机床获悉,由通用技术集团与东方电气集团联合研发的4台高端五轴联动数控机床12日在沈阳下线交付。这一合作在取得重大技术突破的同时,还打破了“研用脱节”的产业困境,开创了国产工业母机研制的新模式。长期以来,国产高端数控机床面临“研发投入大、周期长、验证难”的系统性瓶颈——企业闭门研发与市场实际需求脱节,产品因缺乏真实工况下的长期验证,陷入“用户不愿用、不敢用,技术难迭代、难成熟”的恶性循环,严重制约产业高质量发展。(中新网)

2小时前

金融时报:将坚持内需主导放在首位

金融时报评论员发布文章称,12月10日至11日,中央经济工作会议在京举行。会议聚焦“当前怎么看”和“明年怎么干”,为中国经济高质量发展把舵定向。站在“十四五”规划收官与“十五五”规划谋篇的历史交汇点,会议强调持续扩大内需、优化供给,将“坚持内需主导,建设强大国内市场”确定为明年经济工作重点任务之首。未来一个时期,我国国内市场主导国民经济循环的特征将更为明显。在内外部发展环境更趋严峻复杂的大背景下,只有坚持立足国内,全方位扩大内需、建设强大国内市场,增强发展主动性,才能够在国际风云变幻中,牢牢把握发展主动权。着眼明年经济社会发展目标任务,做强国内大循环,建设强大国内市场,以国内循环的稳定性对冲国际循环的不确定性,必须坚持内需的主导地位。坚持内需主导,全方位扩大国内需求,要大力提振居民消费。坚持内需主导,全方位扩大国内需求,要推动投资止跌回稳。将坚持内需主导放在首位,是党和国家对当前经济形势的深刻洞察。要全面贯彻明年经济工作的总体要求和政策取向,加快培育完整内需体系,形成消费和投资相互促进的良性循环,将超大规模市场的潜力转化为现实增长动力。

2小时前

脑虎科技:公司“三全”脑机接口产品成功完成首例临床试验

在今日举行的2025天桥脑科学研究院脑机接口与人工智能论坛中,脑虎科技方面表示,公司自主研发的国内首款、国际第二款内置电池的全植入、全无线、全功能(“三全”)脑机接口产品,在复旦大学附属华山医院毛颖、陈亮教授团队的主持下,成功完成首例临床试验。(财联社)

2小时前

本页详细列出关于朗欧医药LONGER的品牌信息,含品牌所属公司介绍,朗欧医药LONGER所处行业的品牌地位及优势。
咨询